These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 11427271)

  • 1. Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21.
    Waite DC; Jacobson EW; Ennis FA; Edelman R; White B; Kammer R; Anderson C; Kensil CR
    Vaccine; 2001 Jul; 19(28-29):3957-67. PubMed ID: 11427271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.
    Bigaeva E; Doorn Ev; Liu H; Hak E
    PLoS One; 2016; 11(5):e0154757. PubMed ID: 27149269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.
    Evans TG; McElrath MJ; Matthews T; Montefiori D; Weinhold K; Wolff M; Keefer MC; Kallas EG; Corey L; Gorse GJ; Belshe R; Graham BS; Spearman PW; Schwartz D; Mulligan MJ; Goepfert P; Fast P; Berman P; Powell M; Francis D;
    Vaccine; 2001 Feb; 19(15-16):2080-91. PubMed ID: 11228380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.
    Kashala O; Amador R; Valero MV; Moreno A; Barbosa A; Nickel B; Daubenberger CA; Guzman F; Pluschke G; Patarroyo ME
    Vaccine; 2002 May; 20(17-18):2263-77. PubMed ID: 12009282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems.
    Precioso AR; Miraglia JL; Campos LM; Goulart AC; Timenetsky Mdo C; Cardoso MR; Luna E; Mondini G; Guedes Jda S; Raw I
    Vaccine; 2011 Nov; 29(48):8974-81. PubMed ID: 21945258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.
    Bernstein DI; Edwards KM; Dekker CL; Belshe R; Talbot HK; Graham IL; Noah DL; He F; Hill H
    J Infect Dis; 2008 Mar; 197(5):667-75. PubMed ID: 18260764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
    Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
    Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous injection of diclofenac for the treatment of pain following minor orthopedic surgery (DIRECT study): a randomized trial.
    Chiarello E; Bernasconi S; Gugliotta B; Giannini S
    Pain Pract; 2015 Jan; 15(1):31-9. PubMed ID: 24279691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol.
    Doenicke A; Roizen MF; Nebauer AE; Kugler A; Hoernecke R; Beger-Hintzen H
    Anesth Analg; 1994 Nov; 79(5):933-9. PubMed ID: 7978412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
    Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
    Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.
    Gorse GJ; Keitel W; Keyserling H; Taylor DN; Lock M; Alves K; Kenner J; Deans L; Gurwith M
    Vaccine; 2006 Aug; 24(33-34):5950-9. PubMed ID: 16797805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of two formulations of intradermal capsaicin as models of neuropathic pain in healthy volunteers.
    Gustafsson H; Akesson J; Lau CL; Williams D; Miller L; Yap S; Rolan P
    Br J Clin Pharmacol; 2009 Oct; 68(4):511-7. PubMed ID: 19843054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tolerability and pharmacokinetic study of a new injectable formulation of disodium clodronate in healthy female volunteers.
    Poli G; Mariotti F; Corrado ME; Acerbi D
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):145-52. PubMed ID: 15230343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and testing of an improved parenteral formulation of phenytoin using 2-hydroxypropyl-beta-cyclodextrin.
    Blanchard J; Ugwu SO; Bhardwaj R; Dorr RT
    Pharm Dev Technol; 2000; 5(3):333-8. PubMed ID: 10934732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults.
    Nony P; Girard P; Chabaud S; Hessel L; Thébault C; Boissel JP
    Vaccine; 2001 Jun; 19(27):3645-51. PubMed ID: 11395198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial.
    Wu J; Li W; Wang HQ; Chen JT; Lv M; Zhou JC; Liang XF; Fang HH; Liu Y; Liu LY; Wang X; Zhang WL; Zhang XM; Song LF; Qiu YZ; Li CG; Wang JZ; Wang Y; Yin WD
    J Infect Dis; 2010 Sep; 202(5):675-80. PubMed ID: 20632888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.
    Garçon N; Van Mechelen M
    Expert Rev Vaccines; 2011 Apr; 10(4):471-86. PubMed ID: 21506645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.
    Keitel WA; Campbell JD; Treanor JJ; Walter EB; Patel SM; He F; Noah DL; Hill H
    J Infect Dis; 2008 Nov; 198(9):1309-16. PubMed ID: 18808338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular safety of hydroxypropyl-β-cyclodextrin-diclofenac in the management of acute postsurgical pain: a pooled analysis of 2 randomized, double-blind, placebo- and active comparator-controlled phase III clinical trials.
    Gan TJ; Singla N; Daniels SE; Lacouture PG; Min LH; Reyes CR; Carr DB
    J Clin Anesth; 2016 Jun; 31():249-58. PubMed ID: 27185721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propofol in a modified cyclodextrin formulation: first human study of dose-response with emphasis on injection pain.
    Wallentine CB; Shimode N; Egan TD; Pace NL
    Anesth Analg; 2011 Oct; 113(4):738-41. PubMed ID: 21890884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.